Related by context. Frequent words. (Click for all words.) 69 Initiates Phase II 68 leading lipid nanoparticle 68 Completes Patient Enrollment 67 Biomagnetics Diagnostics Corporation 67 oncolytic virus therapies 67 using BioSante patented 67 Lipid Polymer Micelle LPM 67 recombinant biopharmaceutical 66 Inc Therapeutic Competitors 66 MassARRAY R 66 www.vivus.com 66 proprietary biomaterials 65 please visit http:/www.supergen.com 65 unique PER.C6 ® 65 Ibis T# 65 proprietary adenovector technology 65 commercializes therapeutic proteins 65 optical biosensors 64 Files Shelf Registration Statement 64 Prism Pharmaceuticals 64 Dyax logo 64 KL4 surfactant 64 FOLOTYN ® 64 Bayhill Therapeutics 64 MultiCell Technologies 64 regarding Aethlon Medical 64 low toxicity bioscience 64 Alnylam maintains 64 Immunicon Corporation 63 Crucell NV NYSE Euronext 63 Announces Licensing Agreement 63 LungAlert TM 63 reformulates existing FDA 63 Receives Orphan Drug Designation 63 commercial bioproduction 63 Announce Merger Agreement 63 ACLARA 63 * Azixa 63 Presents Positive 63 PARI Pharma 63 novel RNAi therapeutics 63 www.sorin.com 63 Amgen discovers develops 63 stable nucleic acid 63 Affymetrix GeneChip ® 63 immunodiagnostic 63 includes iFinix RealTime 63 Valera Pharmaceuticals 63 anticancer therapeutics 63 visit www.PAREXEL.com 63 staphylococcal vaccines 63 proprietary Mimetic Ligand 63 Locked Nucleic Acid LNA 63 Hybridon 62 David H. Fater 62 synthetic retinoid 62 include bioavailability enhancement 62 xMAP technology 62 manufactures integrated circuits 62 Therapeutic Competitors 62 XL# XL# XL# XL# 62 ParAllele 62 BiTE R 62 trastuzumab DM1 T DM1 62 please visit www.mscsoftware.com 62 produces Chrysler Jeep 62 Amgen discovers develops manufactures 62 ZFP Therapeutics 62 Jumps Higher 62 developing Zerenex TM 62 Hepatitis C Virus HCV 62 Avila Therapeutics 62 novel anti infective 62 Fleximer 62 Inc. NASDAQ MBLX 62 liposomal formulation 62 Sangamo ZFP technology 62 Chemokine Therapeutics 62 non personalized allogeneic 62 EyeGate Pharma 62 recombinant vaccines 62 GTC Biotherapeutics develops 62 electro optic polymer 62 By Neil Osterweil 62 ® bortezomib 62 MediVas 62 ALN TTR 62 Genaera Corporation 62 Sunesis Pharmaceuticals 62 BioMarin develops 62 www.epixpharma.com 62 humanized monoclonal antibodies 62 Panzem R 62 SNALP technology 62 Nasdaq MNKD focuses 62 Attracting Bullish Investors 62 NASDAQ HLCS 62 Archexin 61 Lattice Incorporated 61 markets therapeutic ultrasonic 61 containing surfactant